References

• Mataix-Cols, D., Fernández de la Cruz, L., Monzani, B., Rosenfield, D., Andersson, E., Pérez-Vigil, A., Frumento, P., de Kleine, R. A., Difede, J., Dunlop, B. W., Farrell, L. J., Geller, D., Gerardi, M., Guastella, A. J., Hofmann, S. G., Hendriks, G.-J., Kushner, M. G., Lee, F. S., Lenze, E. J., . . . Ressler, K. J. (2017). D-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders: A systematic review and meta-analysis of individual participant data. JAMA Psychiatry, 74(5), 501–510. https://doi.org/10.1001/jamapsychiatry.2016.3955
• Mitchell, J. M., Ot'alora G., M., van der Kolk, B., Shannon, S., Bogenschutz, M., Gelfand, Y., Paleos, C., Nicholas, C. R., Quevedo, S., Balliett, B., Hamilton, S., Mithoefer, M., Kleiman, S., Parker-Guilbert, K., Tzarfaty, K., Harrison, C., de Boer, A., Doblin, R., Yazar-Klosinski, B., & MAPP2 Study Collaborator Group. (2023). MDMA-assisted therapy for moderate to severe PTSD: A randomized, placebo-controlled phase 3 trial. Nature Medicine, 29(10), 2473–2480. https://doi.org/10.1038/s41591-023-02565-4
• Muthukumaraswamy, S. D., Forsyth, A., & Lumley, T. (2021). Blinding and expectancy confounds in psychedelic randomized controlled trials. Expert Review of Clinical Pharmacology, 14(9), 1133–1152. https://doi.org/10.1080/17512433.2021.1933434
• Nicholson, A. A., Ros, T., Densmore, M., Frewen, P. A., Neufeld, R. W. J., Théberge, J., Jetly, R., & Lanius, R. A. (2020). A randomized, controlled trial of alpha-rhythm EEG neurofeedback in posttraumatic stress disorder: A preliminary investigation showing evidence of decreased PTSD symptoms and restored default mode and salience network connectivity using fMRI. NeuroImage: Clinical, 28, Article 102490. https://doi.org/10.1016/j.nicl.2020.102490
• Sheth, R., Parikh, E., Olayeye, K., Pfeifer, K., & Khanna, D. (2024). The effects of ayahuasca on psychological disorders: A systematic literature review. Cureus, 16(3), Article e55574. https://doi.org/10.7759/cureus.e55574
• Williams, N. R., Sudheimer, K. D., Bentzley, B. S., Pannu, J., Stimpson, K. H., Duvio, D., Cherian, K., Hawkins, J., Scherrer, K. H., Vyssoki, B., DeSouza, D., Raj, K. S., Keller, J., & Schatzberg, A. F. (2018). High-dose spaced theta-burst TMS as a rapid-acting antidepressant in highly refractory depression. Brain, 141(3), Article e18. https://doi.org/10.1093/brain/awx379
• Yermus, R., Bottos, J., Bryson, N., De Leo, J. A., Earleywine, M., Hackenburg, E., Kennedy, S., Kezemidis, M., Kratina, S., McMaster, R., Medrano, B., Mina, M., Morisano, D., Muench, M., Pillai, S., Scharlach, R., Setlur, V., Verbora, M., Wolfson, E., . . . Lo, C. (2024). Ketamine-assisted psychotherapy provides lasting and effective results in the treatment of depression, anxiety, and post-traumatic stress disorder at 3 and 6 months: Findings from a large retrospective effectiveness study. Psychedelic Medicine, 2(2), 87–95. https://doi.org/10.1089/psymed.2023.0021
• Arulpragasam, A. R., Theyel, B., Barredo, J., Pouille, F., Gillotti, J. G., Greenberg, B. D., Wout-Frank, M. V., & Philip, N. S. (2026). Low-intensity focused ultrasound neuromodulation in psychiatric disorders: Mechanisms, models, and missing links. Biological Psychiatry. Advance online publication. https://doi.org/10.1016/j.biopsych.2026.02.019
• Barreto, C., Vila Irigoyen, A., Lopez, O., & Gralnik, L. (2022). Psychostimulants for the treatment of comorbid post-traumatic stress disorder (PTSD) in a patient with attention-deficit/hyperactivity disorder (ADHD): A case report and literature summary. Cureus, 14(8), Article e28199. https://doi.org/10.7759/cureus.28199
• Cherian, K. N., Keynan, J. N., Anker, L., Faerman, A., Brown, R. E., Shamma, A., Keynan, O., Coetzee, J. P., Batail, J. M., Phillips, A., Bassano, N. J., Sahlem, G. L., Inzunza, J., Millar, T., Dickinson, J., Rolle, C. E., Keller, J., Adamson, M., Kratter, I. H., & Williams, N. R. (2024). Magnesium-ibogaine therapy in veterans with traumatic brain injuries. Nature Medicine, 30(2), 373–381. https://doi.org/10.1038/s41591-023-02705-w
• Difede, J., Cukor, J., Wyka, K., Olden, M., Hoffman, H., Lee, F. S., & Altemus, M. (2014). D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: A pilot randomized clinical trial. Neuropsychopharmacology, 39(5), 1052–1058. https://doi.org/10.1038/npp.2013.317
• Duecker, F., & Sack, A. T. (2015). Rethinking the role of sham TMS. Frontiers in Psychology, 6, Article 210. https://doi.org/10.3389/fpsyg.2015.00210
• Han, C., Chen, Z., & Liu, L. (2018). Commentary: Effectiveness of theta burst vs. high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): A randomized non-inferiority trial. Frontiers in Human Neuroscience, 12, Article 255. https://doi.org/10.3389/fnhum.2018.00255
• Kan, R. L. D., Zhang, B. B. B., Zhang, J. J. Q., & Kranz, G. S. (2020). Non-invasive brain stimulation for posttraumatic stress disorder: A systematic review and meta-analysis. Translational Psychiatry, 10(1), Article 168. https://doi.org/10.1038/s41398-020-0851-5
• Khan, A. J., Bradley, E., O'Donovan, A., & Woolley, J. (2022). Psilocybin for trauma-related disorders. Current Topics in Behavioral Neurosciences, 56, 319–332. https://doi.org/10.1007/7854_2022_366
• Lee, Y. H., Zhang, Y., Espinosa Dice, A. L., Li, J. H., Tubbs, J. D., Feng, Y.-C. A., Ge, T., Maihofer, A. X., Nievergelt, C. M., Smoller, J. W., Koenen, K. C., Roberts, A. L., & Slopen, N. (2026). Towards scalable biomarker discovery in posttraumatic stress disorder: Triangulating genomic and phenotypic evidence from a health system biobank. Molecular Psychiatry. Advance online publication. https://doi.org/10.1038/s41380-026-03553-z